Search

We have contributed to the Fraunhofer Institute’s technical questionnaire on the Biotech Act II, the European Commission’s public consultation on this forthcoming legislative initiative, and the

The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of €229.7 million raised by the companies in its ecosystem. Start-ups, spin-offs and

Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.

Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada, Australia and New Zealand.

Joan Martí is Director of Business Strategy at ACCIÓ, the Agency for Business Competitiveness of the Government of Catalonia, where he has accumulated 30 years of experience.

In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to

Now advancing 15 next-generation in vivo therapies through high performance, scalable lentiviral vector manufacturing capabilities.

Investment in R&D by the biotechnology sector increased by 13.9%, reaching €1.46 billion.

Juan Bueren will be one of the keynote speakers at BIOSPAIN 2026, held in Bilbao from September 29 to October 1, the leading biotechnology event in Southern Europe.

The initiative, which will take place on 1 October, will provide an exclusive space for companies and candidates to connect directly, explore new career opportunities, and address the main talent

What used to take days or weeks now takes hours. Ploid AI enables R&D teams to run complex multiomics analyses and automatically generate insights (e.g., publication-ready scientific reports, complex

The company has been included in the World’s Growth Leaders ranking compiled by TIME magazine and Statista, which highlights the publicly traded companies with the strongest growth and financial

Oryzon Genomics, a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating

Spanish biotechnology company BioClonal is advancing a proprietary monoclonal antibody program targeting a novel Alzheimer’s disease-related target and will leverage its participation at BIO

On the occasion of World Multiple Sclerosis Day, we interviewed Sanofi, which has a research line specifically focused on chronic neuroinflammation and its role in disease progression, seeking new

From AseBio, we organized the panel entitled ‘European Biotechnology Act: an opportunity to consolidate Spain as a hub for biotechnological innovation’, within the framework of the XIX Annual

MedTech Barcelona will attend the BIO International Convention 2026, which will take place from June 22 to 25 at the San Diego Convention Center, in collaboration with ICEX. The company’s

Spain is already generating science and innovation in biotechnology. The next challenge is not to produce more evidence, but to translate it into clear, decision-relevant value by connecting health

The Valencia-based company, founded nearly four years ago, moves away from the content marketing agency model to launch a comprehensive digital go-to-market system designed specifically for B2B